...
机译:难治性/复发性 B 细胞淋巴瘤中优化的串联 CD19/CD20 CAR 工程 T 细胞
Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Inst Basic Med, Dept Mol Biol & Immunol, Beijing;
Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Therapeut, Beijing, Peoples R China;
Tsinghua Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Inst Immunol, Minist Educ,Key Lab;
机译:Long-term activity of tandem CD19/CD20 CAR therapy in refractory/relapsed B-cell lymphoma: a single-arm, phase 1-2 trial
机译:Selection process and causes of non-eligibility for CD19 CAR-T cell therapy in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma in a European center
机译:A phase I/II study of 10-min dosing of bendamustine hydrochloride (rapid infusion formulation) in patients with previously untreated indolent B-cell non-Hodgkin lymphoma, mantle cell lymphoma, or relapsed/refractory diffuse large B-cell lymphoma in Japan
机译:Interleukin-10 promoter single nucleotide polymorphism in non-Hodgkin's lymphoma and diffuse large B-cell lymphoma.